September 8, 2015
Vertex to Present at the Morgan Stanley Healthcare Conference on September 16
BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will participate in a fireside chat at the Morgan Stanley Healthcare Conference in New York, NY on Wednesday, September 16th at
11:40 a.m. ET.
The audio portion of management's remarks from the conference will be accessible live through Vertex's website at www.vrtx.com in the "Investors" section under the "Events and Presentations" page. A replay of the conference webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For five years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.
(VRTX-WEB)
View source version on businesswire.com: http://www.businesswire.com/news/home/20150908006655/en/
Vertex Pharmaceuticals Incorporated
Investors:
Michael Partridge, 617-341-6108 or
Kelly Lewis, 617-961-7530 or
Eric Rojas, 617-961-7205
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media